3020 Results for: "Boc-D-Arg-oh.hcl.h2o"

Supplier: Bachem Americas

The amphibian skin is a rich source of antimicrobial peptides, please see the same-named product family Other amphibian peptides as bombesin, caerulein, deltorphin, dermorphin, pseudin, sauvagine, and xenin show considerable pharmacological activity.

Supplier: Bachem Americas

Sequence: H-DL-Met-βNA · HCl

Supplier: Bachem Americas

Sequence: ((RS)-2-Benzyl-3-mercaptopropionyl)-Gly-OH

Supplier: Bachem Americas

Sequence: Dde-Lys(Fmoc)-OH

Supplier: Bachem Americas

Sequence: H-β-Ala-OtBu · HCl

Supplier: Enzo Life Sciences

A FLUOR DE LYS® fluorescent assay system

Supplier: Bachem Americas

Copeptin is a 39 amino acid peptide derived from the vasopressin-neurophysin 2-copeptin precursor.

Supplier: Bachem Americas

Sequence: (H-Cys-OMe)₂ · 2 HCl

Supplier: Bachem Americas

PAR peptides (TRAP peptides and thrombin receptor-like peptides) activate the proteinase-activated receptors PAR-1 to PAR-4.

Supplier: Thermo Scientific

Thermo Scientific Pierce Peptide Retention Standard is a mixture of five c-terminal amide decapeptides that provide reference elution profiles in reverse-phase HPLC.

Supplier: Bachem Americas

Specific substrate for the sucrose-non-fermenting protein kinase (SNF1) from Saccharomyces cerevisiae and its mammalian counterpart, AMP-activated protein kinase (AMPK).

Supplier: Bachem Americas

Sequence: Fmoc-Lys(Dde)-OH

Supplier: MP Biomedicals

Thrombin is the final coagulation protease in regard to hemostasis, promoting both procoagulant and anticoagulant effects. It is a lyophilized powder containing sucrose, sodium chloride and Tris. The predominant form of thrombin in vivo is the zymogen, prothrombin (factor II), which is produced in the liver. The concentration of prothrombin in normal human plasma is 5–10 mg/dL. Prothrombin is a glycoprotein with a glycan content of ~12%.

Supplier: Bachem Americas

Highly specific and reversible direct thrombin inhibitor.

Supplier: Peprotech

SEMAPHORIN 3A Recombinant, Purity: greater than or equal to 95% by SDS-PAGE gel and HPLC, Source: CHO cells, Reactivity: Human, Molecular weight of 226.2 kDa, Synonyms: SEMA3A, SEMAD, Size: 500 uG

Supplier: Bioss

S-tag is the name of an oligopeptide derived from pancreatic ribonuclease A (RNase A). If RNase A is digested with subtilisin, a single peptide bond is cleaved, but the resulting two products remain weakly bound to each other and the protein, called ribonuclease S, remains active although each of the two products alone shows no enzymatic activity. The N-terminus of the original RNase A, also called S-peptide, consists of 20 amino acid residues, of which only the first 15 are required for ribonuclease activity. This 15 amino acids long peptide is called S15 or S-tag.

Supplier: TCI America

CAS Number: 219968-28-2
MDL Number: MFCD06797050
Molecular Formula: C45H53N3O10
Molecular Weight: 795.93
Purity/Analysis Method: >97.0% (HPLC)
Form: Crystal
Melting point (°C): 214
Specific rotation [a]20/D: 50 deg (C=1, CHCl3)
Storage Temperature: <0°C

Supplier: MP Biomedicals

Thrombin is the final coagulation protease in regard to hemostasis, promoting both procoagulant and anticoagulant effects. It is a lyophilized powder containing sucrose, sodium chloride and Tris. The predominant form of thrombin in vivo is the zymogen, prothrombin (factor II), which is produced in the liver. The concentration of prothrombin in normal human plasma is 5–10 mg/dL. Prothrombin is a glycoprotein with a glycan content of ~12%.

Supplier: Bachem Americas

These monosubstituted analogs of ShK toxin, a class of K channel blocking peptide toxins derived from the sea anemone Stichodactyla helianthus, were prepared in order to identify functionally important residues. Hereby it has been shown that the location of Lys²² within a helical structure represents a unique difference between the interactive surfaces of the sea anemone and scorpion toxins.

Supplier: Prosci

PAI-2 is an inhibitory serpin expressed mainly in keratinocytes, activated monocytes, and placental trophoblasts. It exists predominantly as a 47 kDa nonglycosylated intracellular protein which can be induced to be secreted as 60 kDa glycoprotein. The physiological relevance of this property, which is neither a consequence of any mutation in the PAI-2 gene nor associated with any known disorder, is still unclear. However, it appears that the formation of intracellular dormant polymers may be important for the controlled release of the inhibitor from PAI-2 producing cells. Plasma levels of PAI-2 are usually low or undetectable, except during pregnancy and in some forms of monocytic leukemia. Secretion of PAI-2 from the placenta normally occurs during the third trimester of pregnancy and accounts for the dramatic increase in PAI-2 levels (up to 250 ng/mL), which are maintained at these levels until postpartum, and then rapidly decline. In addition to its vital role in protecting the placenta from degradation by uPA and/or uPA-activated proteases, PAI-2 has been shown to be essential for the prevention of metastatic spread of neck, lung and breast cancers. The beneficial effect of PAI-2 seen in these studies is presumed to stem from its ability to inhibit uPA-dependent cell dissemination. PAI-2 has also been reported to inhibit keratinocyte proliferation, and to participate in the innate immune response during viral infection. Recombinant human PAI-2 is a 415-residue nonglycosylated protein.